330 related articles for article (PubMed ID: 30903721)
1. Matrix remodelling and MMP expression/activation are associated with hidradenitis suppurativa skin inflammation.
Sanchez J; Le Jan S; Muller C; François C; Renard Y; Durlach A; Bernard P; Reguiai Z; Antonicelli F
Exp Dermatol; 2019 May; 28(5):593-600. PubMed ID: 30903721
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa.
Kelly G; Hughes R; McGarry T; van den Born M; Adamzik K; Fitzgerald R; Lawlor C; Tobin AM; Sweeney CM; Kirby B
Br J Dermatol; 2015 Dec; 173(6):1431-9. PubMed ID: 26282467
[TBL] [Abstract][Full Text] [Related]
3. The P2X7 Receptor Is Overexpressed in the Lesional Skin of Subjects Affected by Hidradenitis Suppurativa: A Preliminary Study.
Manfredini M; Giuliani AL; Ruina G; Gafà R; Bosi C; Zoppas E; Di Virgilio F; Bettoli V
Dermatology; 2021; 237(1):111-118. PubMed ID: 31454821
[TBL] [Abstract][Full Text] [Related]
4. Inflammation induced changes in the expression levels of components of the microRNA maturation machinery Drosha, Dicer, Drosha co-factor DGRC8 and Exportin-5 in inflammatory lesions of hidradenitis suppurativa patients.
Hessam S; Sand M; Skrygan M; Gambichler T; Bechara FG
J Dermatol Sci; 2016 Jun; 82(3):166-74. PubMed ID: 26917346
[TBL] [Abstract][Full Text] [Related]
5. Targeting the NLRP3 inflammasome reduces inflammation in hidradenitis suppurativa skin.
Moran B; Smith CM; Zaborowski A; Ryan M; Karman J; Dunstan RW; Smith KM; Hambly R; Musilova J; Petrasca A; Fabre A; O'Donnell M; Hokamp K; Mills KHG; Housley WJ; Winter DC; Kirby B; Fletcher JM
Br J Dermatol; 2023 Sep; 189(4):447-458. PubMed ID: 37243544
[TBL] [Abstract][Full Text] [Related]
6. Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa.
Lima AL; Karl I; Giner T; Poppe H; Schmidt M; Presser D; Goebeler M; Bauer B
Br J Dermatol; 2016 Mar; 174(3):514-21. PubMed ID: 26436522
[TBL] [Abstract][Full Text] [Related]
7. Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study.
van der Zee HH; Laman JD; de Ruiter L; Dik WA; Prens EP
Br J Dermatol; 2012 Feb; 166(2):298-305. PubMed ID: 22013960
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β.
van der Zee HH; de Ruiter L; van den Broecke DG; Dik WA; Laman JD; Prens EP
Br J Dermatol; 2011 Jun; 164(6):1292-8. PubMed ID: 21332464
[TBL] [Abstract][Full Text] [Related]
9. The IL-1 Pathway Is Hyperactive in Hidradenitis Suppurativa and Contributes to Skin Infiltration and Destruction.
Witte-Händel E; Wolk K; Tsaousi A; Irmer ML; Mößner R; Shomroni O; Lingner T; Witte K; Kunkel D; Salinas G; Jodl S; Schmidt N; Sterry W; Volk HD; Giamarellos-Bourboulis EJ; Pokrywka A; Döcke WD; Schneider-Burrus S; Sabat R
J Invest Dermatol; 2019 Jun; 139(6):1294-1305. PubMed ID: 30528824
[TBL] [Abstract][Full Text] [Related]
10. 3D-SeboSkin Model for Human ex vivo Studies of Hidradenitis Suppurativa/Acne Inversa.
Hou X; Hossini AM; Nikolakis G; Balthasar O; Kurtz A; Zouboulis CC
Dermatology; 2022; 238(2):236-243. PubMed ID: 34077928
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
12. The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study.
Vossen ARJV; Ardon CB; van der Zee HH; Lubberts E; Prens EP
Br J Dermatol; 2019 Aug; 181(2):314-323. PubMed ID: 30657173
[TBL] [Abstract][Full Text] [Related]
13. High inflammation in hidradenitis suppurativa extends to perilesional skin and can be subdivided by lipocalin-2 expression.
Navrazhina K; Garcet S; Zheng X; Hur HB; Frew JW; Krueger JG
J Allergy Clin Immunol; 2022 Jan; 149(1):135-144.e12. PubMed ID: 34081946
[TBL] [Abstract][Full Text] [Related]
14. Integrating complement into the molecular pathogenesis of Hidradenitis Suppurativa.
Grand D; Navrazhina K; Frew JW
Exp Dermatol; 2020 Jan; 29(1):86-92. PubMed ID: 31688984
[TBL] [Abstract][Full Text] [Related]
15. Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa.
Hessam S; Sand M; Skrygan M; Gambichler T; Bechara FG
Inflammation; 2017 Apr; 40(2):464-472. PubMed ID: 28028756
[TBL] [Abstract][Full Text] [Related]
16. Chitinase-3-like Protein 1 (YKL-40) Is Expressed in Lesional Skin in Hidradenitis Suppurativa.
Salomon J; Piotrowska A; Matusiak Ł; Dzięgiel P; Szepietowski JC
In Vivo; 2019; 33(1):141-143. PubMed ID: 30587614
[TBL] [Abstract][Full Text] [Related]
17. Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa.
Emelianov VU; Bechara FG; Gläser R; Langan EA; Taungjaruwinai WM; Schröder JM; Meyer KC; Paus R
Br J Dermatol; 2012 May; 166(5):1023-34. PubMed ID: 22136668
[TBL] [Abstract][Full Text] [Related]
18. Lesional Inflammatory Profile in Hidradenitis Suppurativa Is Not Solely Driven by IL-1.
Vossen ARJV; van Straalen KR; Florencia EF; Prens EP
J Invest Dermatol; 2020 Jul; 140(7):1463-1466.e2. PubMed ID: 32081612
[No Abstract] [Full Text] [Related]
19. Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model.
Vossen ARJV; van der Zee HH; Prens EP
Front Immunol; 2018; 9():2965. PubMed ID: 30619323
[No Abstract] [Full Text] [Related]
20. Interleukin-36 in hidradenitis suppurativa: evidence for a distinctive proinflammatory role and a key factor in the development of an inflammatory loop.
Hessam S; Sand M; Gambichler T; Skrygan M; Rüddel I; Bechara FG
Br J Dermatol; 2018 Mar; 178(3):761-767. PubMed ID: 28975626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
